Bank Julius Baer & Co. Ltd, Zurich Laboratory Corp Of America Holdings Transaction History

Bank Julius Baer & Co. Ltd, Zurich

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$209.01 - $232.56 $102,414 - $113,954	490 New	490 $107,000
Q3 2022 Nov 04, 2022	SELL	$204.81 - $262.19 $104,043 - $133,192	-508 Reduced 59.48%	346 $71,000
Q2 2022 Jul 22, 2022	BUY	$213.86 - $277.87 $641 - $833	3 Added 0.35%	854 $200,000
Q1 2022 May 09, 2022	BUY	$259.82 - $298.18 $2,858 - $3,279	11 Added 1.31%	851 $224,000
Q4 2021 Feb 15, 2022	BUY	$271.6 - $314.21 $92,344 - $106,831	340 Added 68.0%	840 $264,000
Q3 2021 Nov 12, 2021	SELL	$274.82 - $308.34 $20,886 - $23,433	-76 Reduced 13.19%	500 $141,000
Q2 2021 Jul 23, 2021	SELL	$251.87 - $278.14 $31,483 - $34,767	-125 Reduced 17.83%	576 $159,000
Q1 2021 May 10, 2021	BUY	$204.88 - $255.03 $143,620 - $178,776	701 New	701 $179,000

1.87M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.